About

Rita V. Linkner, MD DABOM

About About About About About About About About About About About About About About About About About About About About About About About About About About About About About About

The Concierge Club

A membership designed for women who want clinical-grade guidance on skincare, acne, hair growth, GLP-1 medications, and hormone health, delivered with the same depth I provide to patients sitting in my exam chair.

Join Club RVL

The RVL Playbook

This program is for physicians. I believe our expertise, prescriptive authority, and time with patients should remain within our control. I share the exact framework behind my concierge micropractice to create a thriving direct-patient practice.

Join The RVL Playbook

Media Appearances

Published Work

  • Topical Tretinoin Use for Photodamage

    The pharmacology behind retinoid use for skin aging — how tretinoin works, when to use it, and why dosing precision matters.

  • Evaluating the Efficacy of Photodynamic Therapy with Aminolevulinic Acid and Microdermabrasion as a Combination Treatment for Acne Scarring

    A split-face investigator-initiated trial examining combination laser and procedural treatment for acne scarring — the science behind the in-office anti-aging method.

  • Efficacy and Safety of Tretinoin 0.025%/Clindamycin Phosphate 1.2% Gel in Combination with Benzoyl Peroxide 6% for Facial Acne Vulgaris

    FDA trial-era research on combination topical therapy for acne — the evidence base behind how I sequence actives in the acne protocol today.

  • Efficacy and Safety of a Ceramide-Containing Moisturizer Followed by Clindamycin Phosphate 1.2%/Benzoyl Peroxide 2.5% Gel

    Barrier-first acne treatment — the clinical evidence for leading with moisturizer before actives, a sequencing principle I apply in practice daily.

  • Bilateral Comparison Study of Pimecrolimus Cream 1% and a Ceramide-Hyaluronic Acid Emollient Foam in the Treatment of Atopic Dermatitis

    A controlled comparison of barrier repair agents — the pharmacokinetic thinking behind choosing the right emollient for a compromised skin barrier.

  • An Investigator-Initiated, Double-Blind, Vehicle-Controlled Pilot Study: Assessment for Tachyphylaxis to Topically Occluded Halobetasol 0.05% Ointment

    A double-blind FDA-style trial conducted during fellowship training — the origin of how I think about compliance curves, dosing thresholds, and diminishing returns in topical therapy.

  • Psoriasis and Vascular Disease — Risk Factors and Outcomes: A Systematic Review

    A 120-citation systematic review on the relationship between skin disease and cardiovascular risk — the early evidence that skin and metabolic health are the same conversation.

View More on Google Scholar

Curriculum Vitae

  • High School Diploma with Cum Laude Honors

    Horace Mann School, Riverdale, NY

  • B.A. with University Honors in Biology

    Johns Hopkins University, Baltimore, MD

  • M.D.

    University of Miami Miller School of Medicine, Miami, FL

  • Medical Intern, Department of Internal Medicine

    St. Vincent's Catholic Medical Center, Manhattan, NY

  • Dermatopharmacology Fellow

    Icahn School of Medicine at Mount Sinai, Department of Dermatology, Manhattan, NY

  • Chief Resident

    Icahn School of Medicine at Mount Sinai, Department of Dermatology, Manhattan, NY

  • CEO & Founder

    RVL Skincare, PC

Most Loved

Follow @ritalinknermd for expert opinions on hot topics like injectables, lasers, and the skincare products worth investing in for youthful, healthy skin.